SOPHiA GENETICS SA·4

Jun 5, 4:02 PM ET

CARDOZA GEORGE 4

4 · SOPHiA GENETICS SA · Filed Jun 5, 2026

Research Summary

AI-generated summary of this filing

Updated

SOPHiA GENETICS (SOPH) CFO George Cardoza Buys 20,000 Shares

What Happened George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), made an open-market purchase of 20,000 common shares on 2026-06-05 at $4.95 per share, for a total transaction value of $99,000. This was a purchase (acquisition) rather than a sale.

Key Details

  • Transaction date: 2026-06-05
  • Transaction type: Open-market purchase (code P)
  • Price per share: $4.95
  • Shares acquired: 20,000
  • Total value: $99,000
  • Shares owned after transaction: Not disclosed in the filing
  • Footnote: Purchase occurred during an open trading window per the company’s insider trading policy (Footnote F1)
  • Filing timeliness: Reported with the same period/date (no late filing noted)

Context

  • Purchases by insiders are often watched by investors as a possible positive signal, but filings are factual records and do not state motivation.
  • This was a straightforward open-market buy (not an option exercise, gift, or tax-related transaction).

Insider Transaction Report

Form 4
Period: 2026-06-05
CARDOZA GEORGE
Chief Financial Officer
Transactions
  • Purchase

    Ordinary Shares

    [F1]
    2026-06-05$4.95/sh+20,000$99,000311,458 total
Footnotes (1)
  • [F1]This purchase was made during an open trading window in accordance with the company's insider trading policy.
Signature
/s/ Elimara Brunetto as Attorney-in-Fact for George Cardoza|2026-06-05

Documents

1 file
  • 4
    wk-form4_1780689734.xmlPrimary

    FORM 4